Gastric sleeve

Roux-en-Y gastric bypass yielded slightly better weight loss at 10 years compared with laparoscopic sleeve gastrectomy according to a recent study published ...

Esophagitis was more prevalent after laparoscopic sleeve gastrectomy, but the cumulative incidence of Barrett esophagus was markedly lower than in previous trials and similar after both procedures. Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Thus, at 10 years, %EWL was greater after laparoscopic Roux-en-Y-gastric bypass and the procedures were not equivalent for weight loss, but both laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y-gastric bypass resulted in good and sustainable weight loss. Median (range) %EWL was 43.5% after laparoscopic sleeve gastrectomy and 50.7% after laparoscopic Roux-en-Y-gastric bypass. This 10-year observational follow-up evaluated patients in the Sleeve vs Bypass (SLEEVEPASS) multicenter equivalence randomized clinical trial comparing laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y-gastric bypass in the treatment of severe obesity in which 240 patients aged 18 to 60 years with median body mass index of 44.6 were randomized to laparoscopic sleeve gastrectomy (n = 121) or laparoscopic Roux-en-Y-gastric bypass (n = 119). The initial trial was conducted from April 2008 to June 2010 in Finland, with last follow-up on January 27, 2021. A study was conducted to compare long-term outcomes of weight loss and remission of obesity-related comorbidities and the prevalence of gastroesophageal reflux symptoms (GERD), endoscopic esophagitis, and Barrett esophagus (BE) after laparoscopic sleeve gastrectomy and LRYGB at 10 years.